Commercialization: Page 118
-
PharmaVoice Team/PharmaVoice
The Medical Affairs-Marketing Connection
The Medical Affairs-Marketing Connection By Denise Myshko A changing regulatory environment is mandating that there is better collaboration between the medical affairs and marketing departments of pharmaceutical companies. These two groups are forging stronger relationshiPS for better product lif...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Product Managers: CEO for a Brand
By Elisabeth Pena Product Managers CEO for A Brand With responsibilities ranging from marketing, branding, manufacturing, clinical affairs, regulatory issues, and life-cycle management, the product manager now needs to be involved in all the stages of the drug’s evolution. Brand Product managers ...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Systems Marketing: Paradigm Shift in Pharmaceutical Marketing Strategy
Systems Marketing A Paradigm Shift in Pharmaceutical Marketing Strategy The opportunity for breakout returns from pharmaceutical marketing won’t come from tweaking the margins and incremental adaptations. It won’t come from creating more – more sales people, more promotion, more press releases, m...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Face in the Crowd: Carrying the Bag with "Pat"
A Face in the Crowd Carrying the Bag with “Pat” One top 10 pharmaceutical company and the – everything from no-access physician offices to developing that elusive one-on-one relationship. An estimated 85,000 sales reps are now in the field, according to a new study by pharmaceutical intelligence ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review For Art’s Sake each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry World Pharma Market Continues to Grow Amid Shifting Trends and Emerging Markets Though the pharmaceutical industry remains one of the most profitable and stable industries, several broad variables are leading to fu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Brand Development: Debunking The Myths and Understanding The Realities
Global Brand Development Debunking The Myths and Understanding The Realities These are not easy times in the pharmaceutical industry, particularly given pressures to increase shareholder return and value, increased focus on price and generic use, a drop off in new chemical entity approvals, and i...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
2nd Chances
2nd Chances By Elisabeth Pena For products that are not performing to expectations, a relaunch can revitalize a stale brand, highlight new clinical evidence, or give a product another chance to reach the patients it was designed to treat. With each therapy that a pharma company produces, the goal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Technology Makes CRM Possible
Technology Makes CRM Possible By Denise Myshko The lifeblood of customer relationship management (CRM) is data. Many pharmaceutical companies are investing in CRM technology projects to capture and better analyze data related to their customers. At its most basic level, CRM is the application of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Richard W. Ashley James White Abbott Laboratories Names New Executives Abbott Laboratories has named Richard W. Ashley to the new position of executive VP of corporate development. Abbott, Abbott Park, Ill., is a global, broad-based healthcare company devoted to the discovery, develop...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies NoInk Communications has released Pharma-SalesAccelerator, a new suite of applications specifically designed to improve productivity and increase performance of pharmaceutical sales organizations. NoInk partnered with Pedi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Eileen M. Lach Wyeth Fills VP, Associate General Counsel Position Wyeth has promoted Eileen M. Lach to the position of VP, corporate secretary, and associate general counsel. Wyeth, Madison, N.J., is a pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
May 2004 The forum for the industry executive Narrowing the GAP Between R&D and Marketing Building Strategic Teams with Marsha Fanucci Trial Coordinators The Front Line Building Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on Your Mind — Opinions More on the New DTC Guidelines PharmaVOICE received an overwhelming number of responses to our January opinion question, which addressed the FDA proposed changes to the regulations that govern the content and format of the product disclaimer or brief summary that mu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Early-stage commercial spending can top $60 million for blockbuster products, according to Cutting Edge Information. With such high commercial investments come equally elevated risks that drugs will fail to reach the market or achieve less than their full commercial potential. It is critical that...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Getting into the details of e-detailing E-detailing is slowly becoming an accepted medium for bringing new information to physicians. It holds the promise of building better relationships with prescribers and other healthcare practitioners. 8 FEATURES Connecting with the community Th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
According to Manhattan Research, 2004 will be the pivotal year for the future of pharmaceutical e-detailing programs. Pharmaceutical companies are finding that although the cost of detailing products to physicians is rising, tangible results are not. E-detailing can strengthen the pharmaceutical-...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE The forum for the industry executive June 2004 integrating e-detailing Into the Overall Strategy contract Manufacturing with Darlene Ryan marketing High-Science Products www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for getting the brand name right What’s in a Name? A new brand name must inherently – through the image it conveys, the way it sounds, and the way it rolls off someone’s tongue – describe the essence of the brand and the advantages that a user would enjoy. Think of how simply and po...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by David Kerr Too Much Material, Too Little Time With market share, revenue goals, and stock prices riding on the success of every new product launch, pharmaceutical companies invest substantial resources to equip their mobile sales teams with the information, training, tools, and sup...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your Mind Opinions 24/7/365 – What Keeps You Going? Putting in the time is no longer an option. Work days are longer; work weeks extend into weekends; and months roll by as the pages fly off the calendar. PharmaVOICE wanted to know what keeps you motivated in this 24/7/365 environment. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies Ventiv Health expands Services Ventiv Health has launched Ventiv Recruitment Services as a stand-alone option to provide clients with targeted, highly effective sales professionals across many therapeutic areas. “Specialty pharma...
By PharmaVoice Team • Jan. 2, 2008
Previous
